Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by RUIMIN MA
Downregulation of miR-544 in Tissue, but Not in Serum, Is a Novel Biomarker of Malignant Transformation in Glioma
Oncology Letters
Cancer Research
Oncology
Related publications
Telomerase Activity: A Biomarker of Cell Proliferation, Not Malignant Transformation
Journal of Urology
Urology
Circulating miR-150 in CSF Is a Novel Candidate Biomarker for Multiple Sclerosis
Neurology: Neuroimmunology and NeuroInflammation
Neurology
Epigenetic Silencing of KAZALD1 Confers a Better Prognosis and Is Associated With Malignant Transformation/Progression in Glioma
Oncology Reports
Medicine
Cancer Research
Oncology
Serum miR-26a as a Diagnostic and Prognostic Biomarker in Cholangiocarcinoma
Oncotarget
Oncology
Downregulation of Serum Exosomal miR‐320d Predicts Poor Prognosis in Hepatocellular Carcinoma
Journal of Clinical Laboratory Analysis
Allergy
Immunology
Biochemistry
Public Health
Medical Laboratory Technology
Clinical Biochemistry
Hematology
Microbiology
Environmental
Occupational Health
Local but Not Systemic Capillary Lactate Is a Reperfusion Biomarker in Experimental Acute Limb Ischaemia
European Journal of Vascular and Endovascular Surgery
Surgery
Cardiovascular Medicine
Cardiology
Circulating FABP4 Is a Prognostic Biomarker in Patients With Acute Coronary Syndrome but Not in Asymptomatic IndividualsSignificance
Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular Medicine
Cardiology
miR-21 Is a Promising Novel Biomarker for Lymph Node Metastasis in Patients With Gastric Cancer
Gastroenterology Research and Practice
Hepatology
Gastroenterology
Soluble Neural-Cadherin as a Novel Biomarker for Malignant Bone and Soft Tissue Tumors
BMC Cancer
Cancer Research
Oncology
Genetics